Claudia Arturo, L. D'Alessandro, M. R. Poggiano, G. Orefice, Antonietta Longobardo, M. Liguori, C. Arcamone, A. Di Scala, Ciro di Gennaro, P. Di Micco
Syncope is a frequent cause of access to emergency departments. Recurrent syncope may be associated with a transient lock of consciousness. When neurological or cardiological common causes of syncope are excluded, rare causes of syncope, such as solid carotid tumors, should be considered. In this study, we report a rare case of left carotid chemodectoma in a patient with frequent access to the emergency room for syncope in which a thorough differential diagnosis has been performed.
{"title":"A rare cause of recurrent syncope: chemodectoma of left carotid","authors":"Claudia Arturo, L. D'Alessandro, M. R. Poggiano, G. Orefice, Antonietta Longobardo, M. Liguori, C. Arcamone, A. Di Scala, Ciro di Gennaro, P. Di Micco","doi":"10.4081/itjm.2023.1585","DOIUrl":"https://doi.org/10.4081/itjm.2023.1585","url":null,"abstract":"Syncope is a frequent cause of access to emergency departments. Recurrent syncope may be associated with a transient lock of consciousness. When neurological or cardiological common causes of syncope are excluded, rare causes of syncope, such as solid carotid tumors, should be considered. In this study, we report a rare case of left carotid chemodectoma in a patient with frequent access to the emergency room for syncope in which a thorough differential diagnosis has been performed.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70231176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Nicoletti, Antonio Bonelli, Rocco Clemente, Simona Ciuffreda, Gaetano Dentamaro, Agata Tiziana La Masa, Vito Lascaro, P. Santarcangelo
We describe a case of adult-onset Still’s disease (AOSD) with secondary macrophage activation syndrome. AOSD is a rare disease with unknown origin. Rarely it’s complicated by secondary macrophage activation syndrome, which is a life-threatening disorder. Because the diagnosis of AOSD is essential for exclusion and complications are life-threatening, it is mandatory for a prompt and extensive diagnostic workup and treatment.
{"title":"Adult-onset Still’s disease with secondary macrophage activation syndrome: a case report","authors":"G. Nicoletti, Antonio Bonelli, Rocco Clemente, Simona Ciuffreda, Gaetano Dentamaro, Agata Tiziana La Masa, Vito Lascaro, P. Santarcangelo","doi":"10.4081/itjm.2023.1595","DOIUrl":"https://doi.org/10.4081/itjm.2023.1595","url":null,"abstract":"We describe a case of adult-onset Still’s disease (AOSD) with secondary macrophage activation syndrome. AOSD is a rare disease with unknown origin. Rarely it’s complicated by secondary macrophage activation syndrome, which is a life-threatening disorder. Because the diagnosis of AOSD is essential for exclusion and complications are life-threatening, it is mandatory for a prompt and extensive diagnostic workup and treatment.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41560396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Bocchi, A. Montagnani, Michele Meschi, F. Pomero, P. Piccolo, A. Valerio, G. Gussoni, D. Manfellotto, F. Dentali, Chronic Kidney Disease and Anaemia In Internal Medicine (CKD-AIM) FADOI Study Group
The presence of anaemia in patients with chronic kidney disease (CKD) is associated with decreased quality of life, along with increased morbidity, mortality, and hospitalization rates. This, in turn, affects healthcare costs and the utilization of medical resources. The mechanisms involved in anaemia of CKD are diverse and complex. They include reduced production of endogenous erythropoietin (EPO), absolute and/or functional iron deficiency (due to inflammation leading to elevated levels of hepcidin), the diminished response of the bone marrow to EPO due to uraemic toxins, the shortened lifespan of red blood cells (RBC), and deficiencies in vitamin B12 or folic acid. [...]
{"title":"FADOI survey on chronic kidney disease and anaemia in internal medicine departments of Italian hospitals","authors":"P. Bocchi, A. Montagnani, Michele Meschi, F. Pomero, P. Piccolo, A. Valerio, G. Gussoni, D. Manfellotto, F. Dentali, Chronic Kidney Disease and Anaemia In Internal Medicine (CKD-AIM) FADOI Study Group","doi":"10.4081/itjm.2023.1605","DOIUrl":"https://doi.org/10.4081/itjm.2023.1605","url":null,"abstract":"The presence of anaemia in patients with chronic kidney disease (CKD) is associated with decreased quality of life, along with increased morbidity, mortality, and hospitalization rates. This, in turn, affects healthcare costs and the utilization of medical resources. The mechanisms involved in anaemia of CKD are diverse and complex. They include reduced production of endogenous erythropoietin (EPO), absolute and/or functional iron deficiency (due to inflammation leading to elevated levels of hepcidin), the diminished response of the bone marrow to EPO due to uraemic toxins, the shortened lifespan of red blood cells (RBC), and deficiencies in vitamin B12 or folic acid. [...]","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48352279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Di Micco, F. F. Bernardi, G. Camporese, Mario Biglietto, A. Perrella, T. Ciarambino, V. Russo, E. Imbalzano
Nattokinase (NK) is a protease derived from food used mainly in the Japanese diet that has several properties. The main activity is related to improving fibrinolytic activities. Other activities have been demonstrated in the regulation of blood pressure by the action toward angiotensin proteases and in the antiplatelet activities. NK can be given orally and reaches its maximal concentration after 12 hours. In addition, an antithrombotic activity based on various NK activities has been proposed. First, increased fibrinolytic activity increases thrombus dissolution and/or the formation of atherosclerotic plaques; second, its enhanced antiplatelet action adds to clot dissolution. All activities have been studied in animals and humans in vitro and in vivo. Relevant adverse effects of NK therapy have not been described, however clinical experience is restricted to case series and volunteers and is not based on clinical studies, thus clinical trials are required to confirm.
{"title":"Nattokinase historical sketch on experimental and clinical evidence","authors":"P. Di Micco, F. F. Bernardi, G. Camporese, Mario Biglietto, A. Perrella, T. Ciarambino, V. Russo, E. Imbalzano","doi":"10.4081/itjm.2023.1583","DOIUrl":"https://doi.org/10.4081/itjm.2023.1583","url":null,"abstract":"Nattokinase (NK) is a protease derived from food used mainly in the Japanese diet that has several properties. The main activity is related to improving fibrinolytic activities. Other activities have been demonstrated in the regulation of blood pressure by the action toward angiotensin proteases and in the antiplatelet activities. NK can be given orally and reaches its maximal concentration after 12 hours. In addition, an antithrombotic activity based on various NK activities has been proposed. First, increased fibrinolytic activity increases thrombus dissolution and/or the formation of atherosclerotic plaques; second, its enhanced antiplatelet action adds to clot dissolution. All activities have been studied in animals and humans in vitro and in vivo. Relevant adverse effects of NK therapy have not been described, however clinical experience is restricted to case series and volunteers and is not based on clinical studies, thus clinical trials are required to confirm.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48581755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Gallucci, Emiliana Marrone, Roberto Nappi, Maurizio Renis, M. Coppola, T. Ciarambino, Daniele D'Ambrosio, A. Maffettone, M. D’avino, Cin Cin For HF Group Researchers
Introduction. The Campania population is characterized by a high incidence and prevalence of heart failure (HF). The aim of this study is to describe the clinical epidemiology, comorbidities, and treatments in HF patients admitted to Internal Medicine Wards (IMW) in Campania. Materials and Methods. It is a retrospective, regional, multicentric, observational study including patients admitted to 15 IMW in Campania, with an HF diagnosis, over a period of three consecutive months. Results. We identified 427 patients, stratified by ejection fraction (EF) category (127 EF≤40%; 216 EF 41-49%; 84 EF≥50%). In comparison with HFpEF subjects, patients with HFrEF were younger (74 years vs. 9 years), more commonly male (67% vs. 32%), and more likely to have an ischaemic aetiology (45% vs. 25%). The most used drugs at the time of hospitalization and after were Diuretics (80.3/93.5%), BBs (69.6/92.6%), and Statins (52.1/63.7%), with statistically significant pre-/post- differences (P≤0.05). Conclusions. EF is more likely to be non-preserved in younger males and in patients with CAD etiology. Hospitalization influences in a statistically significant way the change or adjustment of therapy for almost all drugs.
介绍坎帕尼亚人群的特点是心力衰竭（HF）的发病率和患病率很高。本研究的目的是描述坎帕尼亚内科病房（IMW）HF患者的临床流行病学、合并症和治疗。材料和方法。这是一项回顾性、区域性、多中心的观察性研究，包括连续三个月在坎帕尼亚接受15次IMW诊断为HF的患者。后果我们确定了427名患者，按射血分数（EF）类别分层（127 EF≤40%；216 EF 41-49%；84 EF≥50%）。与HFpEF受试者相比，HFrEF患者更年轻（74岁对9岁），更常见的是男性（67%对32%），更有可能具有缺血性病因（45%对25%）。住院时和住院后使用最多的药物是利尿剂（80.3/93.5%）、BBs（69.6/92.6%）和他汀类药物（52.1/63.7%），前后差异具有统计学意义（P≤0.05）。EF在年轻男性和CAD病因患者中更有可能不被保留。住院以统计学上显著的方式影响几乎所有药物的治疗变化或调整。
{"title":"Results of an observational retrospective multicenter study: “Campania INternal medicine - the Clinical INternist for heart failure”","authors":"F. Gallucci, Emiliana Marrone, Roberto Nappi, Maurizio Renis, M. Coppola, T. Ciarambino, Daniele D'Ambrosio, A. Maffettone, M. D’avino, Cin Cin For HF Group Researchers","doi":"10.4081/itjm.2023.1594","DOIUrl":"https://doi.org/10.4081/itjm.2023.1594","url":null,"abstract":"Introduction. The Campania population is characterized by a high incidence and prevalence of heart failure (HF). The aim of this study is to describe the clinical epidemiology, comorbidities, and treatments in HF patients admitted to Internal Medicine Wards (IMW) in Campania. Materials and Methods. It is a retrospective, regional, multicentric, observational study including patients admitted to 15 IMW in Campania, with an HF diagnosis, over a period of three consecutive months. Results. We identified 427 patients, stratified by ejection fraction (EF) category (127 EF≤40%; 216 EF 41-49%; 84 EF≥50%). In comparison with HFpEF subjects, patients with HFrEF were younger (74 years vs. 9 years), more commonly male (67% vs. 32%), and more likely to have an ischaemic aetiology (45% vs. 25%). The most used drugs at the time of hospitalization and after were Diuretics (80.3/93.5%), BBs (69.6/92.6%), and Statins (52.1/63.7%), with statistically significant pre-/post- differences (P≤0.05). Conclusions. EF is more likely to be non-preserved in younger males and in patients with CAD etiology. Hospitalization influences in a statistically significant way the change or adjustment of therapy for almost all drugs.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49619728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract book of the XXVIII Congresso Nazionale della Società Scientifica FADOI, 6-8 maggio 2023.
2023年5月6日至8日，法多伊科学学会第28届全国大会摘要书。
{"title":"Abstract book of the XXVIII Congresso Nazionale della Società Scientifica FADOI, 6-8 maggio 2023","authors":"Fadoi Scientific Committee","doi":"10.4081/itjm.2023.s1","DOIUrl":"https://doi.org/10.4081/itjm.2023.s1","url":null,"abstract":"Abstract book of the XXVIII Congresso Nazionale della Società Scientifica FADOI, 6-8 maggio 2023.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46366715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dafalla O. Abuidris, O. Abdelbagi, Reem Altayeb, Hiba Elrashid Yagoub, Osama Al-Wutayd, I. Adam, M. Alorini
Cancer is a worldwide health problem, and anemia is one of its manifestations. There are no published data on anemia among patients with cancer in Sudan. The current study aimed to investigate the prevalence of anemia among patients with malignant tumors in central Sudan. The medical records of patients with malignant tumors admitted to the National Cancer Institute, University of Gezira, Sudan, from March to December 2020 were reviewed. Among the 471 patients enrolled in the study, 292 (62.0%) were female. The median (interquartile range, IQR) age was 55 (45-66) years. Breast cancer (109, 23.1%), colorectal/anorectal (88, 18.7%), head and neck (83, 17.6%), female genital tract (70, 14.9%), and prostate (35, 7.4%) cancer were the main cancers observed in this study. The median (IQR) hemoglobin was 11.9 (10.5-13.0) g/dl and 237 (50.3%) patients had anemia. The prevalence of anemia ranged from 31.2% in breast cancer patients to 82.9% in those with prostate cancer. Compared with males (120/292, 41.1%), females (117/179, 65.4%) had a significantly higher prevalence of anemia (P<0.001). The median (IQR) age of the patients with anemia was significantly higher than that of those without anemia (57.0 years vs. 51.5 years, respectively; P=0.003). Half the patients with malignant tumors had anemia. Anemia was more common among female patients and elderly patients.
{"title":"The prevalence of anemia in patients with malignant tumors: a hospital based cross sectional study","authors":"Dafalla O. Abuidris, O. Abdelbagi, Reem Altayeb, Hiba Elrashid Yagoub, Osama Al-Wutayd, I. Adam, M. Alorini","doi":"10.4081/itjm.2023.1571","DOIUrl":"https://doi.org/10.4081/itjm.2023.1571","url":null,"abstract":"Cancer is a worldwide health problem, and anemia is one of its manifestations. There are no published data on anemia among patients with cancer in Sudan. The current study aimed to investigate the prevalence of anemia among patients with malignant tumors in central Sudan. The medical records of patients with malignant tumors admitted to the National Cancer Institute, University of Gezira, Sudan, from March to December 2020 were reviewed. Among the 471 patients enrolled in the study, 292 (62.0%) were female. The median (interquartile range, IQR) age was 55 (45-66) years. Breast cancer (109, 23.1%), colorectal/anorectal (88, 18.7%), head and neck (83, 17.6%), female genital tract (70, 14.9%), and prostate (35, 7.4%) cancer were the main cancers observed in this study. The median (IQR) hemoglobin was 11.9 (10.5-13.0) g/dl and 237 (50.3%) patients had anemia. The prevalence of anemia ranged from 31.2% in breast cancer patients to 82.9% in those with prostate cancer. Compared with males (120/292, 41.1%), females (117/179, 65.4%) had a significantly higher prevalence of anemia (P<0.001). The median (IQR) age of the patients with anemia was significantly higher than that of those without anemia (57.0 years vs. 51.5 years, respectively; P=0.003). Half the patients with malignant tumors had anemia. Anemia was more common among female patients and elderly patients.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44255189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
La terapia antiaggregante nelle sindromi coronariche acute. S. De Servi, A. Landi, C. Montalto, G. Crimi, S. Savonitto La terapia antiaggregante nella vasculopatia cerebrale acuta. M. Giorgi Pierfranceschi Impiego degli anticoagulanti nella fibrillazione atriale. B. Broccatelli, A. Patriarchi, M. Giustozzi, C. Becattini La terapia del tromboembolismo venoso. F. Dentali La terapia anticoagulante nel paziente oncologico. M. Ziliotti, L. Terroni, M.C. Ugolotti, C. Cademartiri La terapia anticoagulante orale nel paziente anziano, fragile o complesso. A. Dellasalda, A.Tedde, D. Arioli
{"title":"Antiaggreganti piastrinici e anticoagulanti: le competenze dell’internista","authors":"Francesco Dentali, M. Silingardi","doi":"10.4081/itjm.q.2023.1","DOIUrl":"https://doi.org/10.4081/itjm.q.2023.1","url":null,"abstract":"\u0000La terapia antiaggregante nelle sindromi coronariche acute. \u0000S. De Servi, A. Landi, C. Montalto, G. Crimi, S. Savonitto \u0000La terapia antiaggregante nella vasculopatia cerebrale acuta. \u0000M. Giorgi Pierfranceschi \u0000Impiego degli anticoagulanti nella fibrillazione atriale. \u0000B. Broccatelli, A. Patriarchi, M. Giustozzi, C. Becattini \u0000La terapia del tromboembolismo venoso. \u0000F. Dentali \u0000La terapia anticoagulante nel paziente oncologico. \u0000M. Ziliotti, L. Terroni, M.C. Ugolotti, C. Cademartiri \u0000La terapia anticoagulante orale nel paziente anziano, fragile o complesso. \u0000A. Dellasalda, A.Tedde, D. Arioli","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47682144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Murzakhmetova, V. Kamkhen, A. Ainabay, Assel M. Meiramova, V. Kemaykin, B. Ainabekova
Hematopoietic stem cell transplantation is a life-saving therapy in patients suffering from acute leukemia. However, kidney complications developed after performing hematopoietic stem cell transplantation can affect the course and prognosis of the disease in patients with acute leukemia. This study is aimed at assessing the functional status of the kidneys in patients with acute leukemia who have undergone hematopoietic stem cell transplantation. The study has observed a group of patients with acute lymphoblastic leukemia and acute myeloid leukemia who have undergone hematopoietic stem cell transplantation. It has been discovered that β2 microglobulin is a sensitive method of analyzing renal function, with the β2 microglobulin threshold urine level not exceeding 0.3 mg/L. The complex diagnostics of kidney function in hematopoietic stem cell transplantation recipients has given the opportunity to identify the relationship between increased β2 microglobulin levels and decreased glomerular filtration rate. It has been determined that β2 microglobulin is a biomarker of renal disorders. The obtained data have showed that β2 microglobulin can be used as a diagnostic marker of reduced kidney function.
{"title":"Association of β2 microglobulin level and glomerular filtration rate in patients with acute leukemia after hematopoietic stem cell transplantation","authors":"A. Murzakhmetova, V. Kamkhen, A. Ainabay, Assel M. Meiramova, V. Kemaykin, B. Ainabekova","doi":"10.4081/itjm.2023.1563","DOIUrl":"https://doi.org/10.4081/itjm.2023.1563","url":null,"abstract":"Hematopoietic stem cell transplantation is a life-saving therapy in patients suffering from acute leukemia. However, kidney complications developed after performing hematopoietic stem cell transplantation can affect the course and prognosis of the disease in patients with acute leukemia. This study is aimed at assessing the functional status of the kidneys in patients with acute leukemia who have undergone hematopoietic stem cell transplantation. The study has observed a group of patients with acute lymphoblastic leukemia and acute myeloid leukemia who have undergone hematopoietic stem cell transplantation. It has been discovered that β2 microglobulin is a sensitive method of analyzing renal function, with the β2 microglobulin threshold urine level not exceeding 0.3 mg/L. The complex diagnostics of kidney function in hematopoietic stem cell transplantation recipients has given the opportunity to identify the relationship between increased β2 microglobulin levels and decreased glomerular filtration rate. It has been determined that β2 microglobulin is a biomarker of renal disorders. The obtained data have showed that β2 microglobulin can be used as a diagnostic marker of reduced kidney function.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42263212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heart failure (HF) is a chronic disease characterized by high morbidity and mortality. FADOI conducted a survey aimed at obtaining information on the management of HF in Italy, with particular reference to the Internal Medicine (IM) Units. The questionnaire, containing 32 questions, was sent to the Directors. Up to August 2022, it was possible to analyze data from140 centers. In 47.4±17.2% of cases with HF, the patients have preserved systolic function; 41% are in NYHA class III, 33% in class IV (33%), 21% and 5% in NYHA class II and I, respectively. The mean length of hospital stay is 9±2.5 days, with an inhospital mortality of 11.9%±9.5%. After discharge, the re-hospitalizations are 21.3±12.7%. In 44.4% of IM departments, there is a formal diagnostic-therapeutic care pathway. Also, through surveys, it is possible to help hospitals to and optimize assistance to patients affected by HF.
{"title":"The management of heart failure: a FADOI survey in the setting of Internal Medicine Units","authors":"F. Gallucci","doi":"10.4081/itjm.2023.1573","DOIUrl":"https://doi.org/10.4081/itjm.2023.1573","url":null,"abstract":"Heart failure (HF) is a chronic disease characterized by high morbidity and mortality. FADOI conducted a survey aimed at obtaining information on the management of HF in Italy, with particular reference to the Internal Medicine (IM) Units. The questionnaire, containing 32 questions, was sent to the Directors. Up to August 2022, it was possible to analyze data from140 centers. In 47.4±17.2% of cases with HF, the patients have preserved systolic function; 41% are in NYHA class III, 33% in class IV (33%), 21% and 5% in NYHA class II and I, respectively. The mean length of hospital stay is 9±2.5 days, with an inhospital mortality of 11.9%±9.5%. After discharge, the re-hospitalizations are 21.3±12.7%. In 44.4% of IM departments, there is a formal diagnostic-therapeutic care pathway. Also, through surveys, it is possible to help hospitals to and optimize assistance to patients affected by HF.","PeriodicalId":43715,"journal":{"name":"Italian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2023-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43258241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：